Abstract
We report on a 30-year-old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations.
Original language | English |
---|---|
Pages (from-to) | 116-118 |
Number of pages | 3 |
Journal | Movement Disorders |
Volume | 21 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2006 |
Keywords
- Myoclunus
- Nootropic drugs
- Piracetam
- SCA2
ASJC Scopus subject areas
- Clinical Neurology
- Neuroscience(all)